MEDIAN Assists in Managing Response to Lung, Liver Therapy

May 26, 2009 - MEDIAN Technologies will feature at SIIM 2009 its MEDIAN LMS-Lung and LMS-Liver solutions, designed to assist clinicians in raising the standards of cancer patient care through the communication of automatic reports containing quantitative and reproducible information about lesion growth for an accurate assessment of response to therapy.
Reports can automatically be done according to the RECIST criteria commonly used for clinical trials. Also included in LMS-Lung is a computer-aided detection function for a more reliable diagnosis of lung nodules.
LMS applications can be integrated with existing RIS/PACS workstations in single or multi-site environments in order to bring advanced clinical functionalities right to the radiologists’ desktop, facilitate the communication between all physicians during tumor boards and standardize reporting across cancer care networks for all patients.


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Lung Imaging

Oct. 20, 2026 — Optellum has announced that its Virtual Nodule Clinic (VNC) with Lung Cancer Prediction (LCP) AI is ...

Time October 21, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Subscribe Now